Inventor
KUEHNE HOLGER
DE37 patents
⚠️ This page may combine multiple inventors who share the name “KUEHNE HOLGER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
32 patentsUS6861440B2Mar 1, 2005
DPP IV inhibitors
HOFFMANN LA ROCHE116 citations98
US6242644B1Jun 5, 2001
N-(4-carbamimidoyl-phenyl)-glycine derivatives
HOFFMANN LA ROCHE56 citations95
US9802944B2Oct 31, 2017
Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
HOFFMANN LA ROCHE20 citations92
US10669285B2Jun 2, 2020
Condensed [1,4] diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
HOFFMANN LA ROCHE9 citations84
US10654857B2May 19, 2020
Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
HOFFMANN LA ROCHE10 citations84
US10640472B2May 5, 2020
Phenoxymethyl derivatives
HOFFMANN LA ROCHE10 citations84
US11098048B2Aug 24, 2021
Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
HOFFMANN LA ROCHE2 citations73
US6683215B2Jan 27, 2004
N-(4-carbamimidoyl-phenyl)-glycine derivatives
HOFFMANN LA ROCHE5 citations73
US6548694B2Apr 15, 2003
N-(4-carbamimidoyl-phenyl)-glycine derivatives
HOFFMANN LA ROCHE8 citations73
US6476264B2Nov 5, 2002
N-(4-carbamimidoyl-phenyl)-glycine derivatives
HOFFMANN LA ROCHE4 citations73
US11352330B2Jun 7, 2022
Phenoxymethyl derivatives
HOFFMANN LA ROCHE1 citations62
US9278918B2Mar 8, 2016
Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors
HOFFMANN LA ROCHE2 citations62
US9199938B2Dec 1, 2015
Aryl-quinoline derivatives
HOFFMANN LA ROCHE2 citations62
US7678818B2Mar 16, 2010
Anthranilamide and 2-amino-heteroarene-carboxamide compounds
HOFFMANN LA ROCHE4 citations62
US7572823B2Aug 11, 2009
Heteroaryl carboxamide compounds
HOFFMANN LA ROCHE2 citations62
US7314884B2Jan 1, 2008
DPP IV inhibitors
HOFFMANN LA ROCHE2 citations62
US7071212B2Jul 4, 2006
N-(4-carbamimidoyl-phenyl)-glycine derivatives
HOFFMANN LA ROCHE1 citations62
US7928106B2Apr 19, 2011
Aza-pyridopyrimidinone derivatives
HOFFMANN LA ROCHE3 citations61
US7674815B2Mar 9, 2010
Heteroaryl and benzyl amide compounds
HOFFMANN LA ROCHE4 citations59
US7259183B2Aug 21, 2007
Indole, indazole and indoline derivatives as CETP inhibitors
HOFFMANN LA ROCHE4 citations59
US9809599B2Nov 7, 2017
Aryl-quinoline derivatives
HOFFMANN LA ROCHE0 citations52
US9604977B2Mar 28, 2017
Bicyclic thiophenylamide compounds
HOFFMANN LA ROCHE1 citations52
US7803819B2Sep 28, 2010
DPP IV inhibitors
HOFFMANN LA ROCHE0 citations52
US7745477B2Jun 29, 2010
Heteroaryl and benzyl amide compounds
HOFFMANN LA ROCHE1 citations51
US9562052B2Feb 7, 2017
Bicyclicpyridine derivatives
HOFFMANN LA ROCHE0 citations42
US9353102B2May 31, 2016
Non-annulated thiophenylamides
HOFFMANN LA ROCHE0 citations42
US10172843B2Jan 8, 2019
Piperidine derivatives
HOFFMANN LA ROCHE0 citations41
US9708340B2Jul 18, 2017
Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors
HOFFMANN LA ROCHE0 citations41
US7691876B2Apr 6, 2010
Heterobicyclic amide compounds
HOFFMANN LA ROCHE0 citations41
US7893099B2Feb 22, 2011
Cyclopentane derivatives
HOFFMANN LA ROCHE0 citations40
US7572801B2Aug 11, 2009
Pyridopyrimidinone derivatives which are HM74A agonists
HOFFMANN LA ROCHE0 citations39
US7964633B2Jun 21, 2011
Sulfonamide derivatives
HOFFMANN LA ROCHE0 citations37